Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

GM Helix Acqua Implant,Ti,5.0X11.5: medical device reports filed with FDA

1,215 reports name it, 2019–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

1,215
device reports naming the brand
0% of all MAUDE reports · about 174 a year
398
reports, 12 months to August 2026
320 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 1,215 reports that name the brand "GM Helix Acqua Implant,Ti,5.0X11.5" (endosseous dental implant), received between July 2019 and August 2026; the manufacturer given most often on reports is Jjgc. Spellings of one product vary from report to report.

398 reports arrived in the 12 months to August 2026, up 24% from 320 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (70.1%), loss of osseointegration (14.2%) and difficult to insert (4%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02855Sep 2021: 6Oct 2021: 6Nov 2021: 11Dec 2021: 32022Jan 2022: 1Feb 2022: 8Mar 2022: 18Apr 2022: 7May 2022: 5Jun 2022: 6Jul 2022: 5Aug 2022: 7Sep 2022: 3Oct 2022: 7Nov 2022: 8Dec 2022: 82023Jan 2023: 9Feb 2023: 10Mar 2023: 10Apr 2023: 18May 2023: 17Jun 2023: 16Jul 2023: 15Aug 2023: 13Sep 2023: 15Oct 2023: 13Nov 2023: 13Dec 2023: 92024Jan 2024: 7Feb 2024: 28Mar 2024: 17Apr 2024: 18May 2024: 14Jun 2024: 20Jul 2024: 28Aug 2024: 30Sep 2024: 35Oct 2024: 13Nov 2024: 22Dec 2024: 312025Jan 2025: 32Feb 2025: 30Mar 2025: 27Apr 2025: 16May 2025: 0Jun 2025: 55Jul 2025: 38Aug 2025: 21Sep 2025: 30Oct 2025: 31Nov 2025: 41Dec 2025: 312026Jan 2026: 24Feb 2026: 24Mar 2026: 38Apr 2026: 38May 2026: 42Jun 2026: 32Jul 2026: 33Aug 2026: 34

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01763522019: 620192020: 2220202021: 6620212022: 8320222023: 15820232024: 26320242025: 35220252026: 2652026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,215
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report73.7%896
Voluntary report0%0
User facility report0%0
Distributor report26.3%319
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate85270.1%62.8%
Loss of osseointegration17314.2%22.4%
Difficult to insertthe device was hard to insert484%0.4%
Fracturea broken bone30.2%1.6%
Separation failure20.2%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis30224.9%
Painpain, site not specified24620.2%
Inflammationinflammation1028.4%
Hemorrhage/blood loss/bleeding645.3%
Swelling/ edema484%
Abscessa collection of pus363%
Hyperresponsive to stimuli242%
Fistula171.4%
Hypersensitivity/allergic reaction131.1%
Tissue damage131.1%
Sinus perforation90.7%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGM Helix Acqua Implant,Ti,5.0X11.5Product code DZEAll MAUDE reports
Reports1,2153,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer73.7%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about GM Helix Acqua Implant,Ti,5.0X11.5 reports

How many FDA reports name GM Helix Acqua Implant,Ti,5.0X11.5?

1,215 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 398 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (70.1%), loss of osseointegration (14.2%), difficult to insert (4%), fracture (0.2%) and separation failure (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (73.7%) and distributor reports (26.3%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that GM Helix Acqua Implant,Ti,5.0X11.5 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.